SpyGlass Pharma Raises $172.5M in Nasdaq IPO, Markets Debut Set for February 6, 2026
SpyGlass Pharma Inc. completed an initial public offering that sold 10,781,250 shares at $16.00 apiece, raising $172.5 million in gross proceeds. The deal included the full exercise of the underwriters' option, and the company's shares began trading on the Nasdaq Global Select Market on February 6, 2026. The SEC declared the registration statement …